Import Document Consistency Checks for Colombia
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Customs clearance creates no new qualification; it tests the consistency between existing qualifications and the shipment at hand. GRZAN groups the clearance documents into four papers: the registration certificate (authorized entity and authorized acts), the CCAA (the importer’s storage and conditioning capability), the commercial invoice (transaction and product name), and the shipping marks and labels (models and packaging units). The checking order must not be reversed – check the registration certificate first, then the CCAA, then the invoice, and finally the marks and models.
The reversed order traps teams in document rework: changing the marks first and only then discovering the certificate model mismatch means changing everything twice. The registration certificate is valid for 10 years and the CCAA for 5 years; the two are out of sync, so a fresh four-paper consistency check must be run before every shipment rather than relying on the previous shipment’s experience.
2. Legal basis
| Regulation | Number | Publication date | Provision |
|---|---|---|---|
| Decreto 4725 de 2005 (medical device registration and vigilance system) | Decreto 4725 de 2005 | December 26, 2005 | Art. 3 (definitions of titular, fabricante, importador) |
| Decreto 4725 de 2005 (medical device registration and vigilance system) | Decreto 4725 de 2005 | December 26, 2005 | Art. 20 (contents of the certificate, including the name and address of the titular) |
| Decreto 4725 de 2005 (medical device registration and vigilance system) | Decreto 4725 de 2005 | December 26, 2005 | Art. 29 (power of attorney, POA) |
| Resolución 4002 de 2007 (storage and conditioning capacity manual) | Resolución 4002 de 2007 | 2007 | CCAA validity of 5 years and the technical director requirement |
| Resolución 1405 de 2022 (semantic standards and UDI-DI) | Resolución 1405 de 2022 | August 8, 2022 | Commercial attributes: commercial description, commercial packaging unit, smallest use unit |
| Resolución 1405 de 2022 (semantic standards and UDI-DI) | Resolución 1405 de 2022 | August 8, 2022 | Basic attributes: UDI-DI, GMDN codes and terminology, registration number |
| Decreto 582 de 2017 (amends 4725/2005) | Decreto 582 de 2017 | April 4, 2017 | Post-grant verification and suspension rules |
| Resolución 4816 de 2008 (national device vigilance program) | Resolución 4816 de 2008 | 2008 | Recalls executed per INVIMA instructions |
3. Expert insights
#### The first paper fixes the entity, the second fixes the premises, and the order cannot be reversed
The registration certificate answers who is allowed to bring the product into Colombia; the CCAA answers where and how the goods are held once they arrive. Only with a lawful entity and compliant premises is there any point discussing the paperwork. The CCAA is valid for 5 years and must be renewed by applying for re-inspection at least 5 business days before expiry (public INVIMA guidance); that short window means certificate gaps tend to occur exactly when everyone assumes the certificate is still valid.
#### Model consistency has moved into the structured data layer
Resolución 1405 de 2022 defines the commercial attributes as the commercial description, the commercial packaging unit and the smallest use unit, alongside the basic attributes of UDI-DI, GMDN code and registration number. After INVIMA confirmed by official communication on March 12, 2026 that semantic reporting is fully mandatory, model and packaging hierarchy are no longer free text on paper labels but data that must align with the UDI records. One model written on the invoice, another on the marks and a third registered in the semantic report amount, in verification, to one shipment that cannot be traced.
#### Marks and packaging units are the highest-frequency rework point
The recurring issues GRZAN observes concentrate on packaging hierarchy: the certificate is registered by smallest use unit, the shipment is packed by carton, and the marks show only the carton count without the smallest-unit quantity. Such problems do not require re-registration, but the mark template must be fixed before shipment – cheap at the factory, expensive as port demurrage. Given that Colombia depends on imports for roughly 80%–85% of its device supply, the cumulative cost of this rework is substantial.
#### Liability when the chain breaks should be written into agreements in advance
The four papers belong to different parties: the certificate to the titular, the CCAA to the importer, the invoice and marks executed by the manufacturer and the freight forwarder. Without prior allocation, demurrage and return-shipment costs will circulate unresolved among the three parties. GRZAN recommends stating in the distribution and logistics agreements that demurrage caused by one party’s document error is borne by that party.
4. Practical recommendations
- Manufacturer export specialist: build a pre-shipment four-paper checklist and confirm it in signature order: certificate, then CCAA, then invoice, then marks.
- Importer: before shipment, provide current proof of the CCAA validity period and covered premises, archived by the manufacturer.
- GRZAN regulatory team: fix the certificate’s model wording as a standard model list, cited uniformly by the invoice, the marks and the semantic report.
- Packaging design: make the mark template show both the smallest use unit quantity and the commercial packaging unit, aligned with the commercial attributes of Resolución 1405 de 2022.
- Legal counsel: stipulate in the distribution agreement how liability for demurrage caused by document errors is allocated and evidenced.
- Quality department: archive the model consistency check records for every batch for retrieval during post-grant verification.
5. Verification checklist
- □ The certificate is within validity (devices 10 years; IVD class III 5 years) and the authorized act is importar y vender
- □ The titular name on the certificate is consistent with the POA and the invoice seller chain
- □ The importer’s CCAA is within its 5-year validity and covers the actual warehouse
- □ The commercial invoice product name matches the registered name on the certificate
- □ The mark models match the standard model list and the UDI-DI records
- □ The marks show both the smallest use unit and the commercial packaging unit
- □ Batch consistency check records are archived
- □ Demurrage liability clauses are agreed in the distribution/logistics agreements
- GRZAN regulatory team
Regulatory information verified as of October 29, 2026
All conclusions published here are based on the current regulatory texts issued by the competent authority and are verified item by item before delivery.
GRZAN helps manufacturers and importers keep the Colombian document chain consistent from certificate to shipping marks, with local licensed-entity and importer support, model-list governance and fee budgeting for corrections. For a pre-shipment document consistency review, contact us at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us